Bisphosphonate-containing vaccine pharmaceutical composition for humoral immunity
AssigneeNitto Denko Corporation
InventorsTakuya Shishido, Daisuke Asari, Mitsuhiko Hori
Life of this patent
Estimating the term…
Abstract
The present invention aims to provide a vaccine pharmaceutical composition universally usable for induction of humoral immunity against various antigens and exerting a high antibody production inducing effect. The present invention relates to a vaccine pharmaceutical composition for inducing humoral immunity, including: an antigen; and an immunity induction promoter that is a bisphosphonate.
Claims14
A vaccine pharmaceutical composition for inducing humoral immunity in a subject, comprising:
- an antigen;
- and
- a bisphosphonate;
- wherein the vaccine pharmaceutical composition is structured and arranged to be administered transdermally and/or transmucosally and, upon administration to the subject, is capable of inducing a humoral immune response in the subject.
A method for inducing humoral immunity, comprising transdermally or transmucosally administering to a subject a vaccine pharmaceutical composition comprising:
- an antigen;
- and
- a bisphosphonate,
- wherein the administration induces a humoral immune response in the subject.
Dependencies are inferred from the claim text.